Deep Science Ventures and Medicines Discovery Catapult have launched a [...]

US regulators have unveiled new guidance and funding initiatives aimed [...]

NICE has issued draft final guidance recommending Nucala as an [...]

Pierre Fabre Laboratories has received a positive opinion from the [...]

Mestag Therapeutics has dosed the first patient in its Phase [...]

With 89% of AI pilots failing to scale, biopharmas can [...]

EPIK Biosciences has launched as a new psychedelic drug development [...]

Incannex Healthcare has said its PSX-001 oral synthetic psilocybin programme [...]

Remepy has announced a collaboration with Merck KGaA, Darmstadt Germany, [...]

Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]